SCHEMBL4942389

SCHEMBL4942389

CCCCC1[CH]CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6561460 0.93 EPHX1 (0.38)
SCHEMBL3034508 0.93 CYP1A2 (0.46)
SCHEMBL4450962 0.91 EPHX1 (0.41)
SCHEMBL27513432 0.91 EPHX1 (0.41)
SCHEMBL14109298 0.91 CYP1A2 (0.50)
SCHEMBL9214351 0.91 EPHX1 (0.41)
SCHEMBL9474195 0.91 EPHX1 (0.41)
SCHEMBL9335628 0.91 CYP1A2 (0.50)
SCHEMBL14109090 0.88
SCHEMBL9591949 0.87 CYP1A2 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6071846-A OLEFIN POLYMERIZATION CATALYST WHICH ALLOWS A POLYOLEFIN TO HAVE HIGH STEREOREGULARITY AND HIGH POLYMERIZATION ACTIVITY; SOLID TITANIUM CATALYST COMPONENT COMPRISES A MAGNESIUM ATOM, TITANIUM ATOM, HALOGEN ATOM AND ELECTRON DONOR TOKUYAMA CORPORATION (JP) 2000-06-06 US claimed
EP-0464487-A1 Optically active alpha-fluoro-acrylamides, their preparation, polymers thereof and their use in the separation of racemates BAYER AG (DE) 1992-01-08 EP claimed
CN-104583199-A 2-aminopyrazine derivatives as CSF-1R kinase inhibitors CHROMA THERAPEUTICS LTD 2015-04-29 CN disclosed
US-8545783-B2 Acid gas absorbent, acid gas removal method, and acid gas removal device KABUSHIKI KAISHA TOSHIBA (JP) 2013-10-01 US disclosed
US-20120308451-A1 ACID GAS ABSORBENT, ACID GAS REMOVAL METHOD, AND ACID GAS REMOVAL DEVICE KABUSHIKI KAISHA TOSHIBA (JP) 2012-12-06 US disclosed
EP-2529824-A1 Acid gas absorbent, acid gas removal method, and acid gas removal device Kabushiki Kaisha Toshiba (JP) 2012-12-05 EP disclosed
CN-101074227-B Phosphine acyloxy quinazoline derivatives and their medicine uses ASTRAZENECA AB 2010-09-29 CN disclosed
US-20080293898-A1 Catalyst for Olefin Polymerization and Polymerization Method Using the Same MITSUI CHEMICALS, INC. (JP) 2008-11-27 US disclosed
CN-101074227-A Phosphine acyloxy quinazoline derivatives and their medicine using ASTRAZENECA AB (SE) 2007-11-21 CN disclosed
CN-100349906-C Phosphonoxyquinazoline derivatives and pharmaceutical use thereof ASTRAZENECA AB (SE) 2007-11-21 CN disclosed
EP-1783145-A1 OLEFIN POLYMERIZATION CATALYST AND METHOD OF POLYMERIZATION USING THE CATALYST Mitsui Chemicals, Inc. (JP) 2007-05-09 EP disclosed
EP-0605180-A1 Polypropylene composition MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1994-07-06 EP disclosed
EP-0585869-A1 Solid titanium catalyst component for olefin polymerization, process for preparing the same, catalyst for olefin polymerization and process for olefin polymerization MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1994-03-09 EP disclosed
US-5120738-A Cardiovascular disorders FUJIREBIO INC. (JP) 1992-06-09 US disclosed
EP-0464487-A1 Optically active alpha-fluoro-acrylamides, their preparation, polymers thereof and their use in the separation of racemates BAYER AG (DE) 1992-01-08 EP disclosed
EP-0421441-A2 Pantothenic acid derivatives FUJIREBIO INC. (JP) 1991-04-10 EP disclosed
EP-0100630-B1 PROSTAGLANDIN E1 ANALOGUES ONO PHARMACEUTICAL CO., LTD. (JP) 1986-04-02 EP disclosed
US-4473587-A PREVENTION OF CYTODAMAGE TO GASTROINTESTINAL SYSTEM OR LIVER ONO PHARMACEUTICAL CO., LTD. (JP) 1984-09-25 US disclosed
EP-0100630-A2 Prostaglandin E1 analogues ONO PHARMACEUTICAL CO., LTD. (JP) 1984-02-15 EP disclosed
US-4376094-A Method of disinfecting and a method for destroying bacteria and fungi using 2-substituted glutaraldehydes STERLING DRUG INC. (US) 1983-03-08 US disclosed